Aethlon medical to release fiscal third quarter financial results and host conference call on february 12, 2025

San diego , feb. 5, 2025 /prnewswire/ -- aethlon medical, inc. (nasdaq: aemd), a medical therapeutic company focused on developing products to treat cancer and life threatening infectious diseases, today announced that it will issue financial results for its fiscal third quarter ended december 31, 2024, at 4:15 p.m. et on wednesday, february 12, 2025.
AEMD Ratings Summary
AEMD Quant Ranking